Skip to main content
OpenTrials

Clinical trial condition

PD-L1 Positive

Explore clinical trials studying PD-L1 Positive. Study availability and eligibility vary by location and protocol.

7 public trials 1 recruiting study
Refine in advanced search Browse all conditions

PD-L1 Positive trial results

Active, Not Recruiting

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

NCT02955290

Conditions
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Squamous Non-Small Cell Lung Carcinoma, Bronchial Neoplasms, +29 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • St. Francis Hospital Roslyn, New York, United States
  • Good Samaritan Hospital West Islip, New York, United States
View Trial Details
Active, Not Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

NCT05382286

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Arizona Oncology Associates, PC-Hope,1845 W Orange Grove Rd Tucson, Arizona, United States
  • Arizona Oncology Associates, PC-Hope,2070 W. Rudasill Rd. Tucson, Arizona, United States
  • Arizona Oncology Associates, PC-Hope Tucson, Arizona, United States
View all 504 locations
View Trial Details

Related conditions